NEW YORK CITY (Reuters) – Morgan Stanley has actually boosted its 12-month base instance rate …
Read More »US FDA grants accelerated approval to Genfit and Ipsen’s liver disease drug
By Puyaan Singh and Mariam Sunny (Reuters) -The U.S. Food and Drug Administration granted accelerated approval to French drugmakers Ipsen and Genfit’s drug for a chronic inflammatory liver disease, Iqirvo, the companies said on Monday. Primary biliary cholangitis (PBC) causes inflammation of the small bile ducts in the liver and eventually destroys them. It primarily affects women aged 30 to …
Read More »